Our findings of increased ESRD risk in variant SOD2 Val/Val carriers is aligned with several studies concluding that this polymorphism increases the risk of diabetic nephropathy in both T1DM and T2DM patients [9,10,15]. This evidence concerns the gene SOD2 and type 1 diabetes mellitus.